Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
about
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancerA highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumNephrocalcinosis (enamel renal syndrome) caused by autosomal recessive FAM20A mutationsMass spectrometry for translational proteomics: progress and clinical implicationsSolid-phase extraction strategies to surmount body fluid sample complexity in high-throughput mass spectrometry-based proteomicsCandidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical studyA systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analysesWhat was old is new again: using the host response to diagnose infectious disease.ICan: an optimized ion-current-based quantification procedure with enhanced quantitative accuracy and sensitivity in biomarker discoveryMultidimensional Separation Using HILIC and SCX Pre-fractionation for RP LC-MS/MS Platform with Automated Exclusion List-based MS Data Acquisition with Increased Protein Quantification.Towards an animal model of ovarian cancer: cataloging chicken blood proteins using combinatorial peptide ligand libraries coupled with shotgun proteomic analysis for translational researchImmunodepletion of high-abundant proteins from acute and chronic wound fluids to elucidate low-abundant regulators in wound healingMulti-dimensional liquid chromatography in proteomics--a review.Combinatorial peptide ligand library treatment followed by a dual-enzyme, dual-activation approach on a nanoflow liquid chromatography/orbitrap/electron transfer dissociation system for comprehensive analysis of swine plasma proteome.A posteriori quality control for the curation and reuse of public proteomics data.High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity.Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer."The quest for biomarkers": are we on the right technical track?Plasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomicsDepletion of abundant plasma proteins and limitations of plasma proteomics.Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.Improved LC-MS/MS spectral counting statistics by recovering low-scoring spectra matched to confidently identified peptide sequences.Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid.The vasculome of the mouse brain.Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.Protein biomarkers of ovarian cancer: the forest and the treesProteome-wide light/dark modulation of thiol oxidation in cyanobacteria revealed by quantitative site-specific redox proteomics.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjectsAutomated sample preparation platform for mass spectrometry-based plasma proteomics and biomarker discoveryPlasma biomarker discovery using 3D protein profiling coupled with label-free quantitation.Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes.A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.IgY14 and SuperMix immunoaffinity separations coupled with liquid chromatography-mass spectrometry for human plasma proteomics biomarker discovery.Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling.Development of a New Ion Mobility (Quadrupole) Time-of-Flight Mass Spectrometer.Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.
P2860
Q21134794-FA9ACC31-4A46-4CD2-841C-436AC7ACF7DBQ24307894-344D9EA9-5CCF-46E0-B008-D10B627638E9Q24319733-032D1D71-FE59-49B0-BF5B-467D880C2034Q26995497-6C34545D-ED7F-46BE-BA1D-DF019391770AQ28650185-56E1F836-D554-42D9-B56C-270FACFF9703Q28730283-61517A62-A1EF-4141-99F4-A269C0762312Q28732696-B91BAFF2-9A6F-493D-BCE2-3BAA6BD2B94DQ30376327-D160561D-9F86-488C-82CB-3BEADEC9D4A8Q30606993-54C460AE-E04C-4EFD-840E-CC230724257CQ31039634-6CBB288D-9DD5-4D6C-886F-1A92A0AA8509Q33576391-9A466315-561A-4BF1-8B61-37BA7D653136Q33771167-E4D11A33-3CC0-446D-B501-C0DB709F34A4Q33779558-5290A57B-F45C-4890-B2AB-2E004DD9ADD6Q33872613-E2331C0B-53C0-4056-9C75-58A046EBCFF0Q33888463-32736625-8ADE-4027-8111-E69111BC5FD3Q33900798-C0F25F2E-16B1-4616-A8B2-585794969272Q33915813-45ADF7BF-A0B0-4063-AEEA-DAE0E415A00FQ34116103-64C34300-0FB8-4E2C-8A96-B46FF6C2A472Q34154148-8088A7C7-5C2A-4ABE-9340-415720A69249Q34168719-4250B9E1-A6A2-4EA7-B67F-C4D9AB4C3632Q34242987-C43E67B8-2066-4D28-8017-6BB963B58038Q34283162-DFC96A3B-F217-443F-9E9A-2CCEE77BE35CQ34401658-7A30C23E-CD76-4DFD-AB2D-43CC653AFCB9Q34534371-12DDACAB-9E02-4EE3-8052-81AC1BB82F6DQ34551781-C447F6D4-2712-4DC3-98BC-B03438A8AB5AQ34634143-D3A9C3C1-009B-4FFB-93A2-40EA49C18A3EQ34634874-303F6DBD-824F-48CB-B6C8-35B4A9207D3FQ34958895-BC32B59D-4CD1-447E-A790-BBBDF5F7DBA2Q35083863-838C671B-2271-42C7-91FA-F11A735955A0Q35169652-D27E8DF2-BB3C-4388-8CA2-66707DC63FBAQ35169971-731B58C4-B438-45AE-A841-B1770A1ECB0EQ35190564-0B827D54-32A6-4060-A801-746D712561A3Q35620650-19583383-374D-47AB-AE10-F28AA3BA951CQ35680919-AA7C8C3A-DEF3-4832-849C-AA1541B1A313Q35835036-A3E04853-6346-4BDE-ABEA-43601A947350Q35849260-A0D27159-4F61-4380-A049-CC1E2966D29EQ36031629-DB1C1445-8A8D-42F1-B676-87F8D0A13491Q36040373-C596F35C-A36A-4D06-B717-56DD46EC82F6Q36040379-1AB9E2F2-6A59-4C69-8256-488442E5D4A3Q36136098-ABA159EC-CD30-41CB-B1C7-72918B5F0B44
P2860
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Enhanced detection of low abun ...... oaffinity separation strategy.
@en
type
label
Enhanced detection of low abun ...... oaffinity separation strategy.
@en
prefLabel
Enhanced detection of low abun ...... oaffinity separation strategy.
@en
P2093
P2860
P50
P1476
Enhanced detection of low abun ...... noaffinity separation strategy
@en
P2093
Brianne O Petritis
David G Camp
David T Kaleta
Heather M Mottaz
Hongliang Jiang
Susan M Varnum
Wei-Wei Zhang
Xiangming Fang
P2860
P304
P356
10.1074/MCP.M800008-MCP200
P577
2008-07-15T00:00:00Z